Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immortalized, homozygous stat1-deficient mammalian cell lines and their uses

Immortalized, homozygous stat1-deficient mammalian cell lines and their uses

US Patent 6740519 · Granted May 25, 2004

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant Newcastle disease viruses and uses thereof for the prevention of RSV2025
Recombinant Newcastle disease viruses and uses thereof for the prevention of RSV2025
Recombinant Newcastle disease viruses and uses thereof for the prevention of RSV2025
Mosaic influenza virus hemagglutinin polypeptides and uses thereof2025
Mosaic influenza virus hemagglutinin polypeptides and uses thereof2025
Influenza virus hemagglutinin proteins and uses thereof2025
Influenza virus hemagglutinin proteins and uses thereof2025
Newcastle disease viruses and uses thereof2024
Newcastle disease viruses and uses thereof2024
Anti-influenza B virus neuraminidase antibodies and uses thereof2024
Anti-influenza B virus neuraminidase antibodies and uses thereof2024
Influenza virus hemagglutinin proteins and uses thereof2024